RNF6 promotes chronic myelogenous leukemia cell proliferation and migration by stabilizing vimentin via multiple atypical ubiquitinations

RNF6 promotes chronic myelogenous leukemia cell proliferation and migration by stabilizing vimentin via multiple atypical ubiquitinations

Bibliographic Details
Main Authors:	Hongxia Zhang, Yueya Zhong, Yuanming He, Yujia Xu, Ying Ren, Haixia Zhuang, Tong Sun, Zhigang Zhu, Xinliang Mao
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2024-01-01
Series:	Genes and Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352304223001800

Similar Items

Suppression of USP7 induces BCR-ABL degradation and chronic myelogenous leukemia cell apoptosis
by: Shuoyi Jiang, et al.
Published: (2021-05-01)

BECN1 promotes the migration of NSCLC cells through regulating the ubiquitination of Vimentin
by: Zhujun Cheng, et al.
Published: (2019-01-01)

The Role of Tissue-Specific Ubiquitin Ligases, RNF183, RNF186, RNF182 and RNF152, in Disease and Biological Function
by: Takumi Okamoto, et al.
Published: (2020-05-01)

RNF11 at the Crossroads of Protein Ubiquitination
by: Anna Mattioni, et al.
Published: (2020-11-01)

RNF112-mediated FOXM1 ubiquitination suppresses the proliferation and invasion of gastric cancer
by: Shengwei Zhang, et al.
Published: (2023-06-01)

UCHL3 promotes hepatocellular carcinoma cell migration by de-ubiquitinating and stabilizing Vimentin
by: Qiancheng Ma, et al.
Published: (2023-03-01)

Expression and activity of Fyn mediate proliferation and blastic features of chronic myelogenous leukemia.
by: Melissa M Singh, et al.
Published: (2012-01-01)

RNF180 Inhibits Proliferation and Promotes Apoptosis of Colorectal Cancer Through Ubiquitination of WISP1
by: Feng Wei, et al.
Published: (2021-01-01)

Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches
by: Panagiotis T. Diamantopoulos, et al.
Published: (2021-11-01)

Ubiquitin ligase RNF125 targets PD-L1 for ubiquitination and degradation
by: Meng Wei, et al.
Published: (2022-07-01)

Characterization of the Roles of Vimentin in Regulating the Proliferation and Migration of HSCs during Hepatic Fibrogenesis
by: Pei-Wen Wang, et al.
Published: (2019-10-01)

Apoptosis resistance in chronic myelogenous leukemia
by: Fabíola Attié de Castro, et al.
Published: (2005-09-01)

Bosutinib in the management of chronic myelogenous leukemia
by: Keller-von Amsberg G, et al.
Published: (2013-05-01)

Molecular basis of Acute Myelogenous Leukemia
by: Eduardo M. Rego
Published: (2002-01-01)

Saponins From Paris forrestii (Takht.) H. Li Display Potent Activity Against Acute Myeloid Leukemia by Suppressing the RNF6/AKT/mTOR Signaling Pathway
by: Qin Lu, et al.
Published: (2018-06-01)

Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase.
by: Kolas, N, et al.
Published: (2007)

Orchestration of the DNA-Damage Response by the RNF8 Ubiquitin Ligase
by: Kolas, N, et al.
Published: (2007)

Stabilization of nuclear oncoproteins by RNF4 and the ubiquitin system in cancer
by: M. Diefenbacher, et al.
Published: (2017-01-01)

Occurrence of chronic lymphocytic leukemia in patients with chronic myelogenous leukemia
by: Pritish K Bhattacharyya
Published: (2013-01-01)

Analysis of telomere length in chronic myelogenous leukemia.
by: Boultwood, J, et al.
Published: (1997)

Analysis or telomere length in chronic myelogenous leukemia
by: Fidler, C, et al.
Published: (1998)

A mathematical model of chronic myelogenous leukemia
by: Neiman, B
Published: (2000)

Supremacy of nanoparticles in the therapy of chronic myelogenous leukemia
by: Gopalarethinam Janani, et al.
Published: (2023-09-01)

Green crystals of death in chronic myelogenous leukemia
by: Mohammad Esmaeil Khedmati, et al.
Published: (2022-01-01)

Applications of Microarray Technology to Acute Myelogenous Leukemia
by: Rashmi S. Goswami, et al.
Published: (2009-01-01)

Wnt Signaling Pathway and Chronic Myelogenous Leukemia
by: HOU Yan, et al.
Published: (2019-02-01)

Spotlight on nilotinib in the treatment of chronic myelogenous leukemia
by: Harnicar S, et al.
Published: (2014-08-01)

Applications of Microarray Technology to Acute Myelogenous Leukemia
by: Rashmi S. Goswami, et al.
Published: (2009-01-01)

PRRSV Non-Structural Proteins Orchestrate Porcine E3 Ubiquitin Ligase RNF122 to Promote PRRSV Proliferation
by: Ruiqi Sun, et al.
Published: (2022-02-01)

Assesment Of The Efficacy Of HESA-A On The Proliferation And Apoptosis Of Chronic Myelogenous Leukemia Cell Line(K562)
by: Mahdihe Ghasemi, et al.
Published: (2012-11-01)

Assesment Of The Efficacy Of HESA-A On The Proliferation And Apoptosis Of Chronic Myelogenous Leukemia Cell Line(K562)
by: Mahdihe Ghasemi, et al.
Published: (2012-12-01)

LINC01559 promotes lung adenocarcinoma metastasis by disrupting the ubiquitination of vimentin
by: Hao Feng, et al.
Published: (2024-02-01)

The role of RNF149 in the pre-emptive quality control substrate ubiquitination
by: Aster Legesse, et al.
Published: (2023-04-01)

Inhibition of cholesterol biosynthesis through RNF145-dependent ubiquitination of SCAP
by: Li Zhang, et al.
Published: (2017-10-01)

Role of the Ubiquitin Ligase RNF149 in the Development of Rat Neonatal Gonocytes
by: Gurpreet Manku, et al.
Published: (2022-05-01)

UBC13 is an RNF213‐associated E2 ubiquitin‐conjugating enzyme, and Lysine 63‐linked ubiquitination by the RNF213‐UBC13 axis is responsible for angiogenic activity
by: Toshiyuki Habu, et al.
Published: (2021-04-01)

Chronic myelogenous leukemia: molecular monitoring in clinical practice
by: N. R. Ryabchikova, et al.
Published: (2014-07-01)

Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-07-01)

Chronic myelogenous leukemia: molecular monitoring in clinical practice
by: N. R. Ryabchikova, et al.
Published: (2014-07-01)

Nephrotic syndrome as the first manifestation of Acute Myelogenous leukemia
by: Mohammadali Mashhadi
Published: (2010-07-01)